You were right a buy-out was announced. A buy-out of Cameron Health by Boston Scientific.
We have seen all the issues as of late around the leads in an ICD system. The leads in an ICD system are the most likely part by far to fail and render the device useless to the patient it is implanted in. Well this is a leadless defibrillator that is implanted Sub-Q. An easy implant procedure coupled with fixing the most common mode of failure. It will be interesting to see how it does once it hits the marketplace.
Cameron has all the patents on this and is well through most the clinical trial process. BSX will be the only company to offer this technology in the near future.